Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis by Harrill, Joshua A. et al.
Lineage-Dependent Effects of Aryl Hydrocarbon
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Rodent cancer bioassays indicate that the aryl hydrocarbon receptor (AHR) agonist,
2,3,7,8-tetracholorodibenzo-p-dioxin (TCDD), causes increases in both hepatocytic and
cholangiocytic tumors. Effects of AHR activation have been evaluated on rodent hepatic
stem cells (rHpSCs) versus their descendants, hepatoblasts (rHBs), two lineage stages of
multipotent, hepatic precursors with overlapping but also distinct phenotypic traits. This
was made possible by defining the first successful culture conditions for ex vivo mainte-
nance of rHpScs consisting of a substratum of hyaluronans and Kubota’s medium (KM),
a serum-free medium designed for endodermal stem/progenitor cells. Supplementation of
KM with leukemia inhibitory factor elicited lineage restriction to rHBs. Cultures were
treated with various AHR agonists including TCDD, 6-formylindolo-[3,2-b]carbazole
(FICZ), and 3-3’-diindolylmethane (DIM) and then analyzed with a combination of
immunocytochemistry, gene expression, and high-content image analysis. The AHR ago-
nists increased proliferation of rHpSCs at concentrations producing a persistent AHR
activation as indicated by induction of Cyp1a1. By contrast, treatment with TCDD
resulted in a rapid loss of viability of rHBs, even though the culture conditions, in the
absence of the agonists, were permissive for survival and expansion of rHBs. The effects
were not observed with FICZ and at lower concentrations of DIM. Conclusion: Our find-
ings are consistent with a lineage-dependent mode of action for AHR agonists in rodent
liver tumorigenesis through selective expansion of rHpSCs in combination with a toxicity-
induced loss of viability of rHBs. These lineage-dependent effects correlate with increased
frequency of liver tumors. (HEPATOLOGY 2015;61:548-560)
T
he aryl hydrocarbon receptor (AHR) is a
ligand-activated transcription factor from the
basic-helix-loop-helix/Per-ARNT-Sim (bHLH/
PAS) superfamily.1 Ligand activation triggers nuclear
translocation of the receptor, dissociation of AHR
from a HSP90/AIP/p23 multi-protein chaperone com-
plex, and dimerization with aryl hydrocarbon receptor
nuclear translocator (ARNT). The activated AHR/
ARNT complex binds dioxin-response elements
(DREs) in the upstream promoter of AHR-regulated
genes and modulates their expression.1 AHR regulates
a diverse array of target genes including xenobiotic
metabolizing enzymes,1 cell cycle proteins,2 ribosyl-
transferases,3 and others.1 Ligands for AHR include
persistent organic pollutants such as 2,3,7,8-tetracholor-
odibenzo-p-dioxin (TCDD) and other polyhalogenated
and nonhalogenated polycyclic aromatic hydrocarbons,
tryptophan UV-photoproducts (FICZ), dietary indole-
3-carbanol derivatives (DIM), and molecules endoge-
nous to the liver such as 3-indoxyl sulfate.1,4,5
Potent xenobiotic AHR ligands, such as TCDD
(Supporting Fig. S1), produce toxicities in rodents,
including hepatotoxicity, immune suppression, epithe-
lial hyperplasia, and tumor promotion in multiple tis-
sues.1 Activation of AHR (Fig. S2) is a key event in
these toxicities given that AHR knockout mice are
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insensitive to TCDD-mediated effects.6,7 Chronic
administration of TCDD to female rats produces path-
ological changes including hepatocellular hypertrophy,
an increased frequency of multinucleated hepatocytes,
proliferation of hepatic stem/progenitors, and infiltra-
tion of them into the hepatic lobule.8,9 The pathologi-
cal changes culminate in both hepatocytic and
cholangiocytic tumors,8 implicating TCDD-induced
oncogenic effects on hepatic stem/progenitors.10,11
Lineage stages of hepatic parenchyma and their part-
ner mesenchymal cells begin with biliary tree stem cells
(BTSCs) in peribiliary glands (PBGs)12; transitioning to
hepatic stem cells (HpSCs) and hepatoblasts (HBs) in/
near canals of Hering13; continuing to acinar plates of
parenchymal cells; and ending with terminally differen-
tiated cells pericentrally.14 Phenotypic properties change
stepwise, correlating with gradients in matrix chemistry
and other paracrine signals. Stem cell niches are
enriched in hyaluronans, fetal laminins, and collagens,
and proteoglycans with negligible/low levels of sulfa-
tion.15 Extensive characterizations in vitro and in vivo
of hBTSCs, hHpSCs, hHBs, and rHBs are summarized
in many articles/reviews.16,17 (See online supplement for
further references.) Here we show that marker analyses
for HpSCs versus HBs in humans and rodents are
almost identical (Supporting Table S3).
In vitro evidence for regulation of progenitor func-
tions by AHR is limited to studies using a transformed
liver progenitor-like cell line (i.e., WB-F344 cells) in
which AHR activation correlates with proliferation
through loss of contact-mediated growth inhibition.18,19
Increases in Jun D expression, cyclin A/cyclin-depend-
ent kinase 2 (CDK2) activity, dysregulation of b-catenin
signaling, and changes in cell-cell adhesion proteins
were observed.19-21 AHR activation has been shown to
modulate cell cycle progression in other transformed cell
lines.1,10 The in vitro effects are consistent with the role
of TCDD as a tumor promoter and indicate that AHR
plays a role in regulating cell proliferation. However, the
effects of AHR on HpSCs of any species have not been
studied. Here we provide the first investigations of
effects of AHR activation on rHpSCs versus rHBs using
a combination of immunocytochemistry and high-
content image analysis.
Materials and Methods
Most methods for cultures were as described
previously.15
Rat Hepatic Stem Cell Cultures. Neonatal
Sprague-Dawley rat livers were enzymatically dispersed
and then cultured on substrata coated with 30 lg/cm2
hyaluronan and in Kubota’s medium (KM).22
Recombinant rat leukemia inhibitory factor (LIF) was
added at concentrations specified in experiments result-
ing in lineage restriction to hepatoblasts.
Chemical Treatments. AHR agonists were pre-
pared in dimethyl sulfoxide (DMSO) at a 1,0003 con-
centration and administered at 1 lL/mL of medium.
Assays. Cultures were analyzed using immunocyto-
chemistry (ICC),15 quantitative reverse-transcription
polymerase chain reaction (qRT-PCR),23 and high
content image analyses.24 (See online supplement for
details of the methods.)
Results
Hyaluronans: Essential Conditions for rHpSCs.
Neonatal rat liver cells were plated into KM and onto
collagen types III, IV, or plastic. Mesenchymal cells
rapidly overgrew cultures, reaching confluence within a
week; parenchymal cell growth was limited (Fig. S5).
In contrast, plating onto hyaluronans and in KM
resulted in coordinated growth responses of parenchy-
mal and mesenchymal cells (Fig. 1A). By 10–12 days,
cells had formed distinct stem/progenitor colonies
(Fig. 1A). Colony sizes increased, indicating prolifera-
tion, and contained both epithelial and mesenchymal
cells. Hepatic lineage markers previously established
for either hHpSCs and hHBs or rHBs (Supporting
Table S3) were used to characterize the cultures using
immunocytochemistry. Both epithelial and mesenchy-
mal cells were positive for CD44, the hyaluronan
receptor (Fig. 1B). The epithelial, but not mesenchy-
mal cells, were positive for E-cadherin, EpCAM, and
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scattered cells for alpha-fetoprotein (AFP) and/or albu-
min (ALB) (Fig. 1B). These phenotypic traits are consist-
ent with mixed cultures of rHpSCs and of rHBs.
Mesenchymal cells coexpressing desmin and CD44 were
hepatic stellate precursors (Fig. 1B) as defined previ-
ously.15 Adult rat hepatocytes did not express EpCAM,
AFP, or CD44 (Fig. S6). ALB and E-cadherin were
expressed by hepatocytes but with a distinct expression
pattern as compared to stem/progenitors. Occasional
desmin1 mesenchymal cells were observed. Thus, hya-
luronans plus KM supported survival and expansion of
hepatic stem/progenitors and their mesenchymal part-
ners. Expansion varied from stable, steady cell divisions
for most colonies to some with limited divisions followed
by degeneration due, we assume, to stem cells present in
stable colonies versus committed progenitors in those
that degenerated.
LIF Enhances Lineage Restriction to and Expan-
sion of rHBs. LIF is an interleukin-6 (IL-6) family
cytokine used to promote expansion of murine embry-
onic stem (ES) cells and is a potent paracrine signal
produced by angioblasts and stellate precursors.15,25
LIF increased desmin1 cell proliferation and, in paral-
lel, lineage restriction to rHBs (Fig. 2A). The time
course of mesenchyal precursor and hepatic stem/
progenitor cell growth was quantified in response to
varying concentrations of LIF (0-10 ng/mL) using
high-content imaging. Concentration-dependent in-
creases in total numbers (Fig. 2B) and areas (Fig. 2C)
of desmin1 cells per well were observed at 6, 9, and
12 days in vitro. For each measurement, the threshold
for statistically significant increases in mesenchymal
precursors was 1 ng/mL with a plateau in effects
observed between 5-10 ng/mL. Similarly, a
concentration-dependent increase in hepatic stem/pro-
genitor-colony areas (Fig. 2D), number of cells/colony
(Fig. 2E), and average number of colonies/well (Fig.
2F) were also observed. Marked increases in colony
area and number of cells/colony occurred at 12 days
in vitro at LIF concentrations 0.5 ng/mL. A less pro-
nounced effect was observed at 9 days in vitro at LIF
concentrations of >1 ng/mL (Fig. 2D,E). A significant
increase in the number of hepatic stem/progenitor col-
onies/well was observed with 0.5-10 ng/mL LIF at
Fig. 1. Hyaluronan promoted selective expansion of rat hepatic stem/progenitor cells in vitro. Cell suspensions from PND0-2 rat livers were
seeded in KM and on 30 lg/cm2 hyaluronan. At 2 days in vitro, unbound cells were rinsed away and selective attachment of small clusters of
cells was observed. (A) Serial imaging of an attached cell cluster between 2 and 10 days in vitro. By 10 days in vitro, attached cell clusters
formed discrete two-dimensional colonies of hepatic stem/progenitor cells in close association with a population of mesenchymal precursors,
operating as feeders. (B) Rat hepatic stem/progenitor colonies cultured for 6 days in vitro were examined for expression of CD44H, E-cadherin,
EpCAM, AFP, ALB, and desmin using immunocytochemistry. Scale bars 5 100 lm.
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6 and 9 days in vitro (Fig. 2F). This effect was less
pronounced at 12 days. The data indicated that LIF
enhanced growth of mesenchymal precursors and
facilitated survival of rHBs. For subsequent experi-
ments, a concentration of 1 ng/mL LIF was used.
LIF-Supplemented Cultures Consisted Primarily
of rHBs. Fluorescent co-labeling with E-cadherin and
ALB demonstrated that LIF-supplemented cultures were
primarily rHBs (Fig. 3; Fig. S3). The rHpSC colonies,
those dominating in LIF-negative cultures, were com-
posed exclusively of tightly-packed cells with little cyto-
plasm, cell surface expression of E-cadherin at
intercellular contact sites, and scattered cells with low or
no ALB expression (Fig. 3A, top row), phenotypic traits
consistent with those of HpSCs.20 The rHB colonies
were comprised of cells with larger cytoplasmic area,
diffuse E-cadherin expression, and with all cells express-
ing ALB and at higher levels (Fig. 3A, middle row) and
AFP (data not shown), phenotypic traits typical of
HBs.13,22 The third type of colony contained a mixture
of rHpSCs and rHBs. The colony (Fig. 3A, bottom
row) shows rHpSCs giving rise to a cord of rHBs.
Variations in patterns of E-cadherin and ALB
immunolabeling were leveraged to quantitatively dis-
tinguish rHpSC and rHB colony types using high-
content imaging. Scatterplots of E-cadherin and ALB
fluorescent surface area densities (FSAD) for colonies
grown in the presence or absence of 1 ng/mL LIF
(Fig. 3B) comprise data in which each point represents
an individual colony. Beginning at 9 days in vitro, a
distinct difference was noted in LIF1 versus LIF– cul-
tures. In LIF1 cultures, colonies with high ALB dif-
ferential intensity values were observed, and these were
largely absent in LIF– cultures (Fig. 3B, red oval). The
differences were more pronounced at 12 days in vitro.
Both culture conditions contained colonies with high
E-cadherin differential intensity values (Fig. 3B, green
oval).
Bipartite gating of E-cadherin and albumin FSAD
values demonstrated that rHpSCs and rHB colonies
could be separated and quantified independently (Fig.
4A,B). Colonies with high ALB and low E-cadherin
FSADs had morphologies consistent with rHBs (Fig.
4C, left column). Colonies with the inverse relationship
Fig. 2. LIF enhanced the growth of rat hepatic stem/progenitors and mesenchymal precursor cells. (A) Rat hepatic stem/progenitors were cul-
tured on 30 lg/cm2 hyaluronan for 12 days in vitro in KM (top row) or KM 1 10 ng/mL LIF (bottom row). Cultures were immunolabeled with
antibodies against desmin (green), ALB (red) and E-cadherin (not shown). Left panels are low-magnification images demonstrating the marked increase
in hepatic stem/progenitor and mesenchymal precursor growth in the presence of LIF. Higher-magnification images of desmin and ALB labeling in colo-
nies grown in the absence or presence of LIF are to the right. Scale bars 5 100 lm. (B) Total number of desmin1 cells per well as determined by
nuclear quantification. (C) Total area of desmin-positive cells per well. (D) Mean hepatic stem/progenitor colony area (lm2), derived from E-cadherin
labeling. (E) Mean number of cells per colony. (F) Mean number of hepatic stem/progenitor cell colonies per well. For all graphs, the bars represent
the mean of three wells/group collected across three independent cultures. The error bars represent the standard deviation across the three independ-
ent cultures. *Significantly different from 0 ng/mL LIF condition within each timepoint (P< 0.05, Tukey’s multiple comparison test).
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(low ALB and high E-cadherin FSADs) had morpholo-
gies consistent with rHpSCs (Fig. 4C, right column).
Neither the number of rHpSC colonies (Fig. 4A,B,
green bubbles) nor the population distribution of
rHpSC colony area measurements (Fig. 4D,E, green
boxplots) was affected by the presence or absence of
LIF. In contrast, rHB colonies were essentially absent in
LIF– cultures (Fig. 4A, red bubbles), whereas large
numbers were present in LIF1 conditions (Fig. 4B, red
bubbles). Quantitatively, the upper limit of the popula-
tion distribution of rHB colony area measurements was
greatly increased in LIF1 as compared to LIF– cultures
(Fig. 4D,E, red boxplots), indicating a stimulatory effect
of LIF on rHB growth.
Quantitative RT-PCR profiling with stage-specific
markers supported the morphological and immunocyto-
chemical results demonstrating the stimulatory effects of
LIF on rHB growth (Fig. 5). A summary of known
hepatic lineage markers (online supplement, Supporting
Table S3) indicates expression of markers in both HpSCs
and HBs (e.g., Epcam, Sox9) (Fig. 5A,B) or in HpSCs
but not HBs (e.g., Ncam) (Fig. 5C) or vice versa (e.g.,
Afp). Ncam increased between 3 and 12 days in vitro in
LIF1 and LIF– cultures. Expression of HBs’ markers
(e.g., Afp, Alb) were minimal in LIF– cultures but
increased or remained constant in LIF1 cultures over
time (Fig. 5D,E), concurrent with the expansion of
rHBs stimulated by LIF (Fig. 4). Expression of BTSC
Fig. 3. LIF promoted the growth of colonies enriched with rHBs. Rat hepatic stem/progenitors were cultured on 30 lg/cm2 hyaluronan in KM
supplemented with 1 ng/mL LIF. (A) At 12 days in vitro, cultures were immunolabeled with E-cadherin (green) and albumin (red). Columns of
images from left to right are as follows: E-cadherin label (green), albumin label (red), and merged fluorescent images. Each row corresponds to
matching images from the same colony. Top row: Consistent with the phenotypic traits of rHpSCs. Middle row: Consistent with traits of rHBs. Bot-
tom row: Consistent with a mixed phenotype colony containing both rHpSCs and rHBs; the rHpSC component of the colony is giving rise to a
cord of rHBs oriented toward the upper right of the image. Scale bars 5 100 lm. (B) Analysis of E-cadherin and ALB fluorescent surface area
densities (FSAD) demonstrates emergence of discrete colony types in the presence of LIF. At 3, 6, 9, and 12 days in vitro, LIF– and LIF1 cul-
tures were immunolabeled with E-cadherin and ALB. Cultures were imaged and analyzed using high-content image analysis. Panels are scatter-
plots of E-cadherin (x-axis) and ALB (y-axis) FSADs with time in LIF– (left) and LIF1 (right) cultures. Each point represents an individual colony.
In the presence of LIF, two discrete populations of colonies emerge at 9 days in vitro and persist at 12 days in vitro. This phenomenon is not
observed in the absence of LIF (compare red ovals across columns). Colony data were pooled across three replicate wells from three independ-
ent cultures.
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markers (e.g., Sox17) decreased over time in both LIF1
and LIF– cultures (Fig. 5F). Together, the data from
high-content imaging and qRT-PCR indicate that LIF is
a requirement for rHBs but not for rHpSCs.
AHR Expression and AHR-Mediated Gene Induction
in Rat Hepatic Stem/Progenitors. The expression of
Ahr and two genes, Ahrr and Cyp1a1, whose transcrip-
tion is induced by AHR activation, were measured in
LIF1 cultures versus hepatocytes (Fig. 6A-C). The
Ahr transcript was detectable, albeit at lower levels
than in hepatocytes. Expression levels remained con-
stant between 3 and 12 days in vitro (Fig. 6A). Ahrr
transcripts were detectable with 10-fold increase in
expression observed between 3-12 days in vitro (Fig.
6B). Ahrr was not detected in hepatocytes. The
Cyp1a1 transcript was also detectable and increased
beginning at 9 days in vitro (Fig. 6C). At 3 and 6
days in vitro, Cyp1a1 expression levels were compara-
ble to that observed in hepatocytes. By 9 and 12 days
in vitro, Cyp1a1 expression was 50-100 times greater
than hepatocytes.
Transcriptional activation of AHR in stem/progeni-
tors was assessed by measuring induction of Cyp1a1
mRNA following acute exposure to three different
AHR agonists—TCDD, FICZ, and DIM (Fig. 6D-F).
Cultures were grown with 1 ng/mL LIF for 12 days in
vitro and then exposed to multiple concentrations of
the test chemicals for 4, 24, 48, and 96 hours. In the
sham (U) or vehicle (V) treatment groups, Cyp1a1
mRNA decreased over time. Concentrations of TCDD
between 0.1 and 100 nM increased Cyp1a1 mRNA
400 to 600-fold by 24 hours; it remained elevated for
the duration of the experiment (Fig. 6D). FICZ at
concentrations of 10 and 100 nM produced a similar
persistent induction of Cyp1a1 mRNA as observed
with TCDD. At lower concentrations of 0.1 and
1 nM FICZ, a transient induction of Cyp1a1 mRNA
occurred (Fig. 6E). DIM at concentrations of 1 and
Fig. 4. High-content image gating analysis and quantification of rHpSC and rHB colony populations. (A,B) Bubble plots of E-cadherin (x-axis)
and ALB (y-axis) FSADs at 12 days in vitro in the absence (LIF–) or presence (LIF1) of 1 ng/mL LIF. Each bubble represents an individual col-
ony. The size of the bubble is proportional to the size of the colony. A bipartite gate was installed which separates a majority (>85%) of colonies
into populations with morphology consistent with either rHBs or rHpSCs. Red bubbles 5 rHBs. Green bubbles 5 rHpSCs. Blue bubbles 5 not clas-
sified. Note the near absence of rHB colonies in cultures maintained in the absence of LIF. (C) Representative images of rHB (left column) and
rHpSC (right column) colony morphology at 12 days in vitro in the presence of 1 ng/mL LIF. Note the differences in E-cadherin and albumin
labeling patterns between colony types. (D,E) Box-and-whisker plots and corresponding histograms for rHB (red) and rHpSC (green) colony sub-
populations in the absence (LIF–) or presence (LIF1) of 1 ng/mL LIF. Stems are the minimum and maximum of colony area measurements. Ver-
tical line 5 population median. 1 5 population mean. Boxes represent the first and third quartiles. Colony data were pooled across three
replicate wells from three independent cultures.
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10 lM produced persistent induction of Cyp1a1
mRNA, albeit at lower levels than that observed with
FICZ or TCDD. DIM at 0.1 lM did not increase
Cyp1a1 mRNA expression. DIM was cytotoxic to
both rHpSCs and rHBs at 100 lM (data not
shown). Thus, AHR is expressed in rat hepatic stem/
progenitors and can be activated in response to various
ligands.
AHR Agonists Affect the Growth Characteristics of
Rat Hepatic Stem/Progenitor Cultures. Rat hepatic
stem/progenitors were treated with three different
AHR agonists (TCDD, FICZ, and DIM) from 2-12
days in vitro and analyzed for changes in growth, mor-
phology, and gene expression. Representative images
from treated cultures (Fig. 7A) demonstrated that
exposure to each AHR agonist produced a marked
increase in growth of rHpSC colonies. Bubble plots
(Fig. 7B) illustrate this phenotypic shift. Compared to
sham or vehicle treatment, cultures exposed to AHR
agonists had greater rHpSC colony sizes using E-
cadherin and ALB FSAD measurements.
Growth characteristics of rHpSC and rHB colonies
in response to varying concentrations of AHR agonists
were quantified and summarized (Fig. 7C,D). TCDD
at concentrations of 0.1 and 1 nM produced a signifi-
cant difference in the distribution of rHpSC colony
area measurements as compared to vehicle controls
(Fig. 7C). The mean colony area increased, as did the
third quartile of colony area measurements, indicating
a net increase in rHpSCs. Similar effects were observed
with FICZ and DIM at concentrations ranging from 1
to 100 nM and 1 to 10 lM, respectively. TCDD at
concentrations of 10 and 100 nM did not affect the
rHpSC colony area measurements, but this may be
Fig. 5. Time course expression of rHpSC and rHB markers with and without LIF supplementation. Rat hepatic stem/progenitors were cultured
on 30 lg/cm2 hyaluronan in KM in the presence (LIF1) or absence (LIF–) of 1 ng/mL LIF. At 3, 6, 9, and 12 days in vitro, RNA was extracted
and analyzed using TaqMan qRT-PCR. Data are expressed as fold-changes from LIF– cultures at 3 days in vitro. For all graphs, the bars represent
the mean of three wells/group collected across three independent cultures. The error bars represent the standard deviation across the three
independent cultures. (A) Epcam, (B) Sox9, (C) Ncam, (D) Afp, (E) Alb, (F) Sox17. Data for each gene were analyzed using a two-way analysis
of variance (ANOVA) followed by Sidak’s multiple comparison test for treatment effects within each timepoint and Tukey’s multiple comparison
test for effects of time within each treatment group. For each gene, within each treatment, bars labeled with the same letter were not significantly
different from one another (Tukey, P< 0.05). Bars denoted with stars indicate a significant difference from the matching timepoint in the absence
of LIF.
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due to the overall decrease in colony numbers per well
(data not shown).
A significant difference in rHB colony area measure-
ments was observed with TCDD treatment. The mean
and third quartile of rHB colony area measurements
were decreased as compared to vehicle controls (Fig.
7D). A similar effect on the distribution of rHB col-
ony area was observed with DIM at concentrations of
1 and 10 lM, but not with FICZ. Thus, there was a
net decrease in rHB colony growth with TCDD and
the two highest concentrations of DIM.
Expression levels of Epcam mRNA (marker of both
HpSCs and HBs20,31) in cultures treated with AHR
agonists were consistent with lineage-stage-specific
effects observed using high content imaging (Fig. 7E).
Treatment with TCDD showed a nonmonotonic
increase in Epcam mRNA with a maximal increase at
0.1 nM followed by a decrease at higher concentra-
tions. Epcam expression was still greater than controls
at the higher TCDD concentrations. Treatment with
FICZ and DIM showed monotonic increases in Epcam
mRNA. The concentration-dependent responses in
Epcam expression for each agonist were consistent with
increased selection and growth of rHpSCs and, in the
case of TCDD, decrease in rHB growth at the higher
concentrations tested.
A similar relationship between high content imaging
and gene expression data for TCDD was observed for
Afp, Alb, and Sox17 (Fig. 7E). TCDD treatment
decreased expression of both Afp and Alb, indicating a
marked loss of rHB colonies. FICZ treatment caused
increased expression in Epcam, a decrease in Alb, and,
at the highest concentration, an increase in Sox17,
effects paralleling those of TCDD; paradoxically, it
also resulted in a modest increase in Afp expression
(Fig. 7E). Treatment with DIM showed similar
changes, but the effects were more muted and not stat-
istically significant (Table 1).
Fig. 6. Expression of Ahr, AHR-responsive genes, and treatment-related increases in Cyp1a1 mRNA in rat hepatic stem/progenitors. (A-C) Rat
hepatic stem/progenitors were cultured on 30 lg/cm2 hyaluronan in KM in the presence of 1 ng/mL LIF. At 3, 6, 9, and 12 days in vitro,
expression of Ahr (A), Ahrr (B), and Cyp1a1 (C) was measured using TaqMan qRT-PCR. Expression of Ahr, Ahrr, and Cyp1a1 was also measured
in hepatocytes isolated from an adult rat liver. Data are expressed as fold-change from cultures sampled at 12 days in vitro. For all graphs, the
bars represent the mean of data from three wells/group collected across three independent cultures. The error bars represent the standard devia-
tion across the three independent cultures. Data for each gene were analyzed using a one-way ANOVA followed by a Tukey’s multiple comparison
test. Bars labeled with the same letter were not significantly different from one another (Tukey, P <0.05). (D-F) Rat hepatic stem/progenitors
were cultured on 30 lg/cm2 hyaluronan in the presence of 1 ng/mL LIF for 12 days. At 12 days in vitro, cultures were treated with varying con-
centrations of AHR agonists and expression of Cyp1a1 was measured using TaqMan qRT-PCR at 4, 24, 48, and 96 hours after exposure. Data
are expressed as fold-change from sham-treated cultures at 4 hours. For all graphs, bars represent the mean of three wells/group collected
across three independent cultures. Error bars represent the standard deviation across the three independent cultures.
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Discussion
To our knowledge, this is the first study in which
successful culture conditions for rHpSCs have been
identified. By contrast, rHBs survive ex vivo using clas-
sical culture conditions, including those with serum
supplementation. The requirements for rHpSCs com-
prise a substratum of hyaluronans in combination with
serum-free KM, a medium designed for endodermal
stem/progenitors and one devoid of cytokines or
growth factors.16,22
Hylauronans are polymers of D-glucuronic acid and
D-N-actetylglucosamine disaccharides, dominant matrix
components of stem cell niches and to which the stem/
progenitors bind by way of CD44, a hyaluronan recep-
tor. Mature cells do not express CD44. The rHpSCs
and rHBs can be distinguished readily by numerous
phenotypic traits and by distinct requirements for their
survival and expansion ex vivo, findings similar to those
for human hepatic stem/progenitors.13,16 Examples
include expression of NCAM only in rHpSCs; of AFP
only in rHBs; minimal (if any) expression of ALB in
rHpSCs versus in all and at much higher levels in
rHBs. Similarly, E-cadherin, found in most hepatic
parenchyma, demonstrated distinctions in cell packing
Fig. 7. AHR agonists affect the growth of rat hepatic stem/progenitors. Rat hepatic stem/progenitors were cultured on 30 lg/cm2 hyaluronan
in KM plus 1 ng/mL LIF. At 2, 5, 8, and 11 days in vitro, media changes were performed with media containing various concentrations of AHR
agonists (TCDD, FICZ, DIM). Cultures were sampled at 12 days in vitro for either high-content imaging or qRT-PCR analysis. (A). Representative
images of hepatic stem/progenitor cultures from high-content image analysis. Red 5 ALB, green 5 E-cadherin. (B) Bubble plots of E-cadherin (x-
axis) and ALB (y-axis) FSADs. Each bubble represents an individual colony. The size of the bubble is proportional to the size of the colony. Gates
are those described in Fig. 5. Red bubbles 5 rHBs, green bubbles 5 rHpSCs, blue bubbles 5 unclassified. (C,D) Box-and-whisker plots of colony
area for colonies classified as rHpSCs (C) or rHBs (D). Stems are the minimum and maximum of colony area measurements. Boundaries of the
box are the first and third quartiles. Vertical line 5 median colony area measurement. 1 5 mean colony area measurement. *Distribution of col-
ony areas is significantly different from vehicle (P< 0.05, Mann-Whitney rank sum test). (E) TaqMan qRT-PCR analysis of Epcam, Sox17, Afp,
and Alb expression. Data are expressed as fold-change from untreated controls. For all graphs, the bars represent the mean of three wells/group
collected across three independent cultures. The error bars represent the standard deviation across the three independent cultures. Data for
each test chemical were analyzed by one-way ANOVA followed by Dunnett’s mean contrast test comparing treated samples to vehicle.
#P< 0.05, ANOVA. *P< 0.05, Dunnett’s. Further details are in Table 1.
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densities and distinct immunocytochemical labeling pat-
terns: dense, cell surface localization of E-cadherin in
rHpSCs and diffuse cell surface, and cytoplasmic local-
ization of E-cadherin in rHBs. Intracellular E-cadherin
and ALB staining patterns provided a means by which
to separate and rapidly quantify the two lineage stages
using a combination of automated image acquisition,
high-content imaging, and a gating strategy similar to
that used in single-cell flow cytometric analyses. Similar
approaches have been used to analyze the heterogeneity
of colony types in human and murine ES cell cultures
exposed to various conditions.24
Hyaluronan receptors are a generic trait of stem/
progenitors26 and are found in a variety of isoforms
resulting from alternative gene splicing.27 Certain var-
iants form multiprotein complexes with EpCAM, clau-
dins, tetraspanins, and integrins and are associated
with metastasis of liver, and other types of cancer.28-31
CD44 expression in liver cancers is negatively associ-
ated with survival prognosis31,32 and has been used to
isolate human cholangiocarcinoma cancer stem cells.33
In rat livers, CD441 cells infiltrate hepatic acini in
response to chemically induced liver injuries triggering
hepatic stem/progenitor proliferation and EpCAM1
cells that can reconstitute damaged livers.34 The
rHpSCs and rHBS have coexpression of CD44 and
EpCAM.
Supplementation with LIF resulted in expansion of
desmin1 mesenchymal precursors and, in parallel, lin-
eage restriction of rHpSCs to rHBs, due presumably
to stellate precursor paracrine signaling. By contrast,
paracrine signals from mature stellate cells result in lin-
eage restriction to diploid, adult hepatocytes, so-called
"small hepatocytes," corroborating prior reports.15
Thus, expansion and survival conditions are lineage
stage-specific in terms of matrix and soluble signals, a
finding similar to that reported previously for human
parenchymal cells.15
LIF stimulated proliferation of desmin1 mesenchy-
mal precursors and, in parallel, lineage restriction of
rHpSCs to rHBs. LIF, a member of the IL-6 growth
factor family, is commonly used to promote expansion
and suppress differentiation of murine ES cells.35 The
role(s) of LIF in rat liver development is not well
defined. However, previous studies have demonstrated
that LIF has a marked proliferative effect on precursors
of endothelia and of vitamin-A-storing stellate cells.25
Both fetal and adult rat hepatocytes express the LIF
receptor, as shown by radioligand binding experiments
with 125I-LIF.36 During chemically induced hepatic
stem/progenitor responses, the expression of LIF and
its cognate cell surface receptor subunits, LIFR and
gp130, become transiently elevated following injury
and are enriched in nonparenchymal cell fractions con-
taining stem/progenitors.37
Intracellular staining patterns to define rHpSCs and
rHBs were assessed by comparative analysis of qRT-
PCR data derived from similarly treated cultures. In
response to LIF, cultures had comparatively higher
mRNA expression of Afp and Alb and other markers
indicating marked rHB growth. Expression levels of
markers specific to rHpSCs (Ncam), of those found in
both rHpSCs and rHBs (Sox9), or in both but
enriched in rHpSCs (Epcam) were similar between
LIF– and LIF1 cultures. Thus, gating of colonies
based on E-cadherin and ALB expression provided
Table 1. Summary of High-Content Imaging and Gene Expression Data in Response to AHR Ligands
Cyp1a1 Induction
rHpSCs rHBs qRT-PCR*
Treatment Dosage (Fold-Change) N† Mean Area (mm2) N† Mean Area (mm2) Epcam Sox 17 AFP ALB
Sham — None 123 8,526 207 25,011 n/a n/a n/a n/a
Vehicle — None 229 17,692 172 23,301 — — — —
TCDD 0.1 nM Persistent (500) 243 31,551‡ 77 16,858‡ Up Up — Down
1 nM Persistent (500) 214 24,975‡ 62 15,222‡ — Up Down Down
10 nM Persistent (500) 143 20,136 39 12,498‡ — Up Down Down
100 nM Persistent (500) 93 16,395 11 9,970‡ — Up Down Down
FICZ 0.1 nM Transient 150 19,411 121 22,610 — — — —
1 nM Transient 251 30,117‡ 186 24,477 — — — —
10 nM Persistent (70) 332 35,574‡ 125 21,337 Up — Up —
100 nM Persistent (120) 194 33,194‡ 56 25,221 Up Up — —
DIM 0.1 mM None 220 17,287 195 21,729 — — — —
1 mM Persistent (9) 294 21,515‡ 199 20,491‡ Up — — —
10 mM Persistent (50) 356 37,007‡ 160 15,860‡ Up — — —
rHpScs 5 rat hepatic stem cells; rHBs 5 rat hepatoblasts.
*Gene expression data presented as directional change from vehicle control. — 5 no change. n/a 5 not applicable.
†N 5 number of colonies.
‡High content image analysis data. Significantly different from vehicle control (P < 0.05, Mann-Whitney rank sum test).
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accurate distinctions between rHpSCs and rHBs and
were used to examine treatment-related effects on dis-
tinct stages of stem/progenitors.
The novel culture system enabled evaluation of
AHR agonist effects on rHpSCs versus rHBs. AHR is
activated by structurally diverse ligands (Fig. S1).
TCDD is an environmental pollutant which is poorly
metabolized by mammalian liver cells and is one of
the most potent AHR agonists known.4 FICZ is a
tryptophan photodegradation byproduct rapidly
metabolized in mammalian liver cells and with a simi-
lar potency for AHR activation as that of TCDD.4
DIM is an indole-3-carbanol derivative in cruciferous
vegetables and is a much less potent AHR agonist
compared to either TCDD or FICZ.4 Using Cyp1a1
expression as a measure of AHR activation,1 differen-
ces in potency and efficacy were observed among the
three ligands. A persistent increase in Cyp1a1 expres-
sion (500-fold) was observed between 24-96 hours
postexposure at all TCDD concentrations examined
(0.1-100 nM). In contrast, FICZ produced a transient
increase in Cyp1a1 expression at 0.1 and 1 nM and a
persistent increase at 10 and 100 nM (70 to 120-
fold). DIM produced a persistent increase in Cyp1a1
expression at 1 and 10 lM, although the efficacy
(9-50-fold) was lower than that observed with either
TCDD or FICZ. The differences in potency between
the three ligands were consistent with previous
reports.4
The persistent increase in Cyp1a1 expression by
TCDD and DIM indicated that these compounds
may be poorly metabolized by rat hepatic stem/pro-
genitors. By comparison, the transient increase in
Cyp1a1 expression observed with lower concentrations
of FICZ (0.1 and 1 nM) indicated that this ligand
may be metabolized by rat hepatic stem/progenitors at
a rate similar to that observed in mature liver cells.38
It is possible that at higher FICZ concentrations
(10-100 nM), the metabolic capacity of the cells is sat-
urated for the treatment paradigm employed (i.e., dose
every 3 days), leading to AHR activation for the dura-
tion of the experiment.
All three AHR ligands stimulated rHpSC colony
growth. However, effects on rHBs were strong by
TCDD and more muted by FICZ and DIM. An
inverted concentration-response was observed for
TCDD in terms of promoting rHpSC colony growth,
with 0.1 and 1 nM TCDD being most effective. The
number of rHB colonies as well as the mean rHB col-
ony area was decreased at all TCDD concentrations.
DIM at 1 and 10 lM had similar effects on rHpSC
and rHB colony growth as compared to TCDD.
FICZ demonstrated distinct characteristics in which
FICZ (1-100 nM) stimulated rHpSC colony growth
but had no effect on rHB colony growth at any con-
centration tested. The underlying cause(s) is unknown
but may be due to differences in potency, efficacy for
AHR activation, or differences in metabolism across
compounds. Alternatively, depletion or down-
regulation of AHR has also been observed following
acute, in vivo exposure to TCDD.39 The effects of
TCDD and DIM at higher concentrations on rHB
growth could potentially be due to AHR depletion.
Overall, high-content imaging and gene expression
data supported that activation of AHR has a stimula-
tory effect on growth of rHpSCs and loss of viability
of rHBs.
Expression patterns of hepatic stem/progenitor
markers were consistent with rHpSC versus rHB
growth patterns observed using high-content imaging.
Patterns of mRNAs in conditions stimulating rHpSC
growth (increases in Epcam and Sox17; decreases in
Alb or Afp) correlated with increases in rHpSC growth
measured in imaging experiments. A similar relation-
ship between high-content imaging and gene expres-
sion data was observed for inhibition of rHB growth.
Decreases in Afp and Alb mRNA expression were
observed in instances where marked rHB growth inhi-
bition occurred, as with TCDD. Modest decreases in
rHBs growth, as with higher concentrations of DIM,
did not produce a concomitant decrease in either Alb
or Afp, confirming that the expression of these genes
correlated with inhibition or absence of rHB growth.
Although FICZ caused increases in Epcam and, at the
highest concentration, elevated Sox17 and lowered Alb,
it also resulted in modestly elevated Afp, a finding per-
haps related to FICZ metabolism in the cells.
Sox17, an endodermal transcription factor, found
consistently in hHpSCs, was variably expressed in
rHpSCs and not at all in hHBs or rHBs. SOX17’s
highest levels have been found in BTSCs.40 In rats,
perhaps expression of SOX17 is restricted to BTSCs
and is not a robust marker for rHpSCs, an hypothesis
being tested. Increased Sox17 mRNA expression was
observed in three of seven conditions in which a sig-
nificant stimulation of rHpSC growth was observed
and in two conditions in which rHpSC colony losses
occurred (i.e., 10 and 100 nM TCDD). The reason
for the discordance is unclear.
Lineage-stage-specific effects of TCDD on rHpSC
and rHB colonies provide insight into a mode-
of-action for TCDD-induced liver tumorigenesis. In
2-year cancer bioassays, female rats were chronically
exposed to TCDD, causing increased incidences of
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hepatocytic and cholangiocytic tumors and increased
stem/progenitor cell proliferation (i.e., an oval cell
response).8,9 Given the ability of rHpSCs and rHBs to
differentiate towards either an hepatocytic or cholan-
giocytic fate, the effects of TCDD implicate a malig-
nant transformation of either one or both. Studies
with WB-F344 cells suggested that TCDD can release
cells from contact-inhibition-mediated cell cycle arrest
and alter expression of cell cycle genes and adhesion
molecules.10,19-21,41 These results have been interpreted
as consistent with activity of TCDD as a nongenotoxic
liver tumor promoter. Our studies implicate a more
complex, lineage-dependent mechanism in which
TCDD stimulates growth of rHpSCs and, in parallel,
causes loss of viability of rHBs. This results in a loss
of feedback loop signals that influences the rHpSCs to
remain quiescent.16,42 Increased proliferation of
rHpSCs could result in an increased likelihood of
acquiring deleterious mutations that could contribute
to oncogenesis. The toxic and carcinogenic potential
of the other two AHR ligands examined, FICZ and
DIM, are considered less than that of TCDD due to
differences in potency, metabolism, and clearance.4
Our findings implicate the importance of lineage-
dependent mechanisms of chemical toxicities and their
influence on liver biology and pathobiology.
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